Effects of pneumococcal conjugate vaccines on reducing the risk of respiratory disease associated with coronavirus infection

Effects of pneumococcal conjugate vaccines on reducing the risk of respiratory disease associated with coronavirus infection

Abstract Pneumococcal conjugate vaccines (PCVs) provide protection against vaccine-type pneumococcal disease in both children and adults. Growing evidence suggests that PCVs also reduce pneumonia and lower respiratory tract infections (LRTIs) more broadly, including protecting against viral-associat...

Full description

Bibliographic Details
Main Authors: Eileen M. Dunne, Marta C. Nunes, Mary P. E. Slack, Christian Theilacker, Bradford D. Gessner
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Pneumonia
Subjects:
Pneumococcal conjugate vaccines
Streptococcus pneumoniae
Pneumococcus
Coronaviruses
SARS-CoV-2
COVID-19
Online Access:https://doi.org/10.1186/s41479-023-00112-w

Internet

https://doi.org/10.1186/s41479-023-00112-w

Similar Items